S. Gaston

发表

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

J. Haines, M. Pericak-Vance, H. Horvitz, 1993, Nature.

Self‐Identified African Americans and prostate cancer risk: West African genetic ancestry is associated with prostate cancer diagnosis and with higher Gleason sum on biopsy

William E Grizzle, Soroush Rais-Bahrami, Peter N Kolettis, 2019, Cancer medicine.

An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer

B. Nicolas Bloch, Robert E. Lenkinski, John V. Frangioni, 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

Nitrocellulose tissue prints: an innovative approach to preparing high quality DNA and RNA from prostate biopsies without compromising the cores for pathology diagnosis

S. Rais-Bahrami, W. Grizzle, G. Kearney, 2018, Translational andrology and urology.

Tissue print micropeel: A new technique for mapping tumor invasion in prostate cancer

M. Upton, S. Gaston, 2006, Current urology reports.

Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer.

C. Becker, B. Zetter, W. DeWolf, 2005, Clinical biochemistry.

Isolation, characterization, and mapping of gene encoding dihydrolipoyl succinyltransferase (E2k) of humanα-ketoglutarate dehydrogenase complex

R. Tanzi, J. Gusella, J. Blass, 1994, Somatic cell and molecular genetics.

Experimental Support for the Possibility of Retrograde Genesis of Intraductal Carcinoma of the Prostate

R. Stoyanova, A. Pollack, W. Tao, 2022, International journal of surgical pathology.

Ligatin binds phosphohexose residues on acidic hydrolases.

K. Kempe, S. Gaston, E. Jakoi, 1981, Journal of supramolecular structure and cellular biochemistry.

Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy

R. Stoyanova, A. Pollack, M. Alhusseini, 2022, Cancers.

Heterogeneity in Genomic Risk Assessment From Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of MRI Targeted Biopsy.

R. Stoyanova, D. Parekh, E. Davicioni, 2020, The Journal of urology.

Brain Ligatin: A Membrane Lectin That Binds Acetylcholinesterase

R. Marchase, S. Gaston, E. Jakoi, 1982, Journal of cellular biochemistry.

Abstract 457: Satisfying the fatty acid demand of prostate cancer: Outlier overexpression of genes involved inde novosynthesis vs fatty acid uptake define two different and potentially synergistic prostate cancer phenotypes

S. Rais-Bahrami, W. Grizzle, J. Nix, 2017 .

IMPLEMENTATION OF PROSTATE BIOPSY TISSUE PRINT TECHNOLOGIES FOR MOLECULAR BIOMARKER STUDIES: MP28‐18

S. Rais-Bahrami, W. Grizzle, J. Nix, 2017 .

Abstract C40: A biopsy-focused approach to molecular studies of prostate cancer in African Americans: the Birmingham Alabama Prostate Cancer Consortium (BAPrCa)

S. Rais-Bahrami, W. Grizzle, J. Nix, 2017 .

1827: Tissue Print Profiling of Prostate Needle Biopsies: Obtaining Comprehensive Tissue Sampling for Molecular Marker Analysis Without Compromising Microscopic Evaluation of the Biopsy Cores

E. Genega, W. C. Wolf, S. Gaston, 2004 .

Inhibition of orthotopic growth and metastasis of androgen‐sensitive human prostate tumors in mice by bioactive soybean components

G. Blackburn, A. Franke, Jin-Rong Zhou, 2002, The Prostate.

Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States

Arul M Chinnaiyan, Martin G Sanda, Mark A Rubin, 2009, Clinical Cancer Research.

The cell cycle and its relevance to the urologist.

W. DeWolf, S. Gaston, 2004, The Journal of urology.

Biomarkers in the Detection of Prostate Cancer in African Americans

W. Grizzle, S. Gaston, 2012 .

BAG-1 Is a Novel Cytoplasmic Binding Partner of the Membrane Form of Heparin-binding EGF-like Growth Factor

M. Freeman, S. Gaston, G. Raab, 2001, The Journal of Biological Chemistry.

Use of thymosin β15 as a urinary biomarker in human prostate cancer

C. Becker, B. Zetter, W. DeWolf, 2005 .

DNA degradation test predicts success in whole-genome amplification from diverse clinical samples.

M. Loda, E. Maher, S. Ogino, 2007, The Journal of molecular diagnostics : JMD.

Genetic heterogeneity of gene defects responsible for familial Alzheimer disease

R. Tanzi, A. Bush, W. Pettingell, 2005, Genetica.

Sequence-tagged sites (STSs) for a set of mapped markers on chromosome 21.

G. D. Stewart, R. Tanzi, J. Gusella, 1992, Genomics.

Genetic and physical mapping of the GLUR5 glutamate receptor gene on human chromosome 21

J. Haines, H. Horvitz, G. Uhl, 1994, Human Genetics.

The Diverse Molecular Nature of Inherited Alzheimer’s Disease

J. Haines, R. Tanzi, P. George-Hyslop, 1994 .

Tissue-print and print-phoresis as platform technologies for the molecular analysis of human surgical specimens: mapping tumor invasion of the prostate capsule

M. Rubin, R. Lenkinski, B. Bloch, 2005, Nature Medicine.

Now what do we do with all these genes? Yeast-based two-hybrid analysis: an emerging technology for molecular urology in the post-genome era.

K. Loughlin, S. Gaston, 1999, Urology.

Determinations of prostate volume at 3-Tesla using an external phased array coil: comparison to pathologic specimens.

Jacob Sosna, Robert E Lenkinski, Neil M Rofsky, 2003, Academic radiology.

Epigenetic risk score improves prostate cancer risk assessment

Wim Van Criekinge, William E. Grizzle, L. van Neste, 2017, The Prostate.

Use of thymosin beta15 as a urinary biomarker in human prostate cancer.

C. Becker, B. Zetter, W. DeWolf, 2005, The Prostate.

Genetic heterogeneity of gene defects responsible for familial Alzheimer disease.

R. Tanzi, A. Bush, W. Pettingell, 1993 .

MP24-05 SELF-IDENTIFIED AFRICAN AMERICANS AND PROSTATE CANCER RISK: WEST AFRICAN GENETIC ANCESTRY IS ASSOCIATED WITH PROSTATE CANCER DIAGNOSIS AND WITH HIGHER GLEASON SUM ON BIOPSY

N. Terrin, R. Kittles, S. Rais-Bahrami, 2019, Journal of Urology.